[LDL apheresis].
Homma
Yasuhiko
Y
Basic Clinical Science, Tokai University School of Medicine.
D000327:Adsorption; D001161:Arteriosclerosis / Q000628:therapy; D001781:Blood Component Removal; D002482:Cellulose; D003131:Combined Modality Therapy; D016264:Dextran Sulfate; D006493:Heparin; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use; D006938:Hyperlipoproteinemia Type II / Q000628:therapy; D007164:Immunosorbents; D008077:Lipoproteins, LDL / Q000302:isolation & purification*; D016032:Randomized Controlled Trials as Topic
D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D007164:Immunosorbents; D008077:Lipoproteins, LDL; D002482:Cellulose; D006493:Heparin; D016264:Dextran Sulfate